Annals of the rheumatic diseases, 73(3), 492-509. BMJ Publishing Group Smolen, J S, Landewe, R, Breedveld, F C, Buch, M, Burmester, G, Dougados, M, Emery, P, Gaujoux-Viala, C, Gossec, L, Nam, J, Ramiro, S, Winthrop, K, de Wit, M P T, Aletaha, D, Betteridge, N, Bijlsma, J W J, Boers, M, Buttgereit, F, Combe, B, Cutolo, M, Damjanov, N, Hazes, J M W, Kouloumas, M, Kvien, T K, Mariette, X, Pavelka, K, van Riel, P L C M, Rubbert-Roth, A, Scholte-Voshaar, M, Scott, D L, Sokka-Isler, T, Wong, JB & van der Heijde, D 2014, ' EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update ', Annals of the Rheumatic Diseases, vol. 73, no. 3, pp. 492-509 . https://doi.org/10.1136/annrheumdis-2013-204573 Annals of the Rheumatic Diseases, 73, 492-509 Annals of the Rheumatic Diseases, 73(3), 492-509. BMJ Publishing Group Annals of the Rheumatic Diseases Annals of the Rheumatic Diseases, 73, 3, pp. 492-509 Annals of the Rheumatic Diseases, 73(3), 492-509